Table 1 Characteristics of 337 Italian subjects treated with smoking-cessation drugs.

From: Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies

Characteristic

N (%) or median (range)

Sex, n (%)

Male

197 (58)

Female

140 (42)

Age at therapy start, years

55 (19–75)

Baseline cigarettes per day, n

20 (1–70)

Baseline eCO, ppm

20 (0–75)

Therapy, n (%)

 Varenicline

225 (66.7)

 Bupropion

34 (10.2)

 NRT

67 (19.8)

 Bupropion + NRT

11 (3.3)

  1. eCO = expired carbon monoxide; NRT = nicotine replacement therapy.